4 ms·
Eli Lilly will soon release key data on its weight loss pill orforglipron
- toomuchtodo 2y agohttps://investor.lilly.com/static-files/cdedba2e-c4a7-4047-9e61-4ac3b1e2cd73 https://investor.lilly.com/static-files/cdedba2e-c4a7-4047-9... (pages 40-41)
- marcod 2y agoFun fact, Orforglipron got named when the lead scientist's cat sat on their keyboard. /s
- loeg 2y agoThis isn't just an oral formulation of tirzepatide, right? The article sort of hints at this but doesn't really come out and say it one way or the other. > Eli Lilly’s pill works in a similar way to Wegovy, Ozempic, and Novo Nordisk’s diabetes pill Rybelsus, targeting a gut hormone called GLP-1 to suppress a person’s appetite and regulate blood sugar. (These three are all just different names for Semaglutide.) > But unlike those three medications, Eli Lilly’s pill is not a peptide medication. > ... > But so-called small molecule pills [orforglipron] will at least be easier for Eli Lilly to manufacture than injections.
- _ihaque 2y agoNo, it's not a reformulation of tirzepatide. Orforglipron is a small molecule with a molecular mass of 883 g/mol and tirzepatide is a large molecule peptide six tims larger, with a molecular mass of 4813 g/mol. The Wikipedia pages are decent -- the picture makes it fairly obvious how much smaller orforglipron is than tirzepatide even if you don't know how to read chemical structures; just count atoms! https://en.wikipedia.org/wiki/Orforglipron https://en.wikipedia.org/wiki/Orforglipron https://en.wikipedia.org/wiki/Tirzepatide https://en.wikipedia.org/wiki/Tirzepatide
- tpm 2y ago> This isn't just an oral formulation of tirzepatide, right? No, the molecule (per wikipedia) is significantly smaller.
- philipkglass 2y agoIt does say it in those two later sentences you quoted: But unlike those three medications, Eli Lilly’s pill is not a peptide medication. But so-called small molecule pills [orforglipron] will at least be easier for Eli Lilly to manufacture than injections. In medicinal chemistry parlance, a "small molecule drug" normally means one that can be synthesized by flasks-and-beakers organic chemistry of the sort one learns in an organic synthesis class. (And it has a lower molecular weight than peptide or biologic drugs, hence the name.) Peptide drugs are synthesized by a specialized kind of organic chemistry that mimics aspects of protein synthesis: https://en.wikipedia.org/wiki/Peptide_synthesis https://en.wikipedia.org/wiki/Peptide_synthesis The industrially relevant thing is that small molecule drugs typically cost less to produce, once the molecule goes into full scale production. Lower cost is an advantage for the first manufacturer while the drug is under patent and it's an advantage for buyers once the drug's patent exclusivity expires.
- loeg 2y agoPerhaps I should have been explicit that I meant "say it explicitly," though I thought it was pretty clear.
- Qem 2y agoIt's a horrible name. I guess we already discovered so many compounds that nice-sounding names are exhausted. If Deflate had not been picked as compression algorithm name, it surely would be a fine name for a weight loss drug.
- timewizard 2y agoIt could be the biggest drug. It might get out of phase 3. It may get approval very soon. And of course, "may be a game changer." When the news is this fast and loose with anything that even looks like a fact how am I not to see this as rank manipulation? There is nothing critical in this article except for how hard doctors and insurance companies might be pressed to prescribe it. Then they end with this gem: "But Seigerman said it will also put pressure on smaller companies developing pills, such as Structure Therapeutics, to find a partner that can help them compete in the weight loss drug market with pharmaceutical behemoths like Eli Lilly. " Oh. I see. It's not just manipulation but dumb protectionist gate keeping. Depressing.
- RedditKon 2y agoPhase 2 clinical trials showed 14.7% mean weight reduction at 36 weeks in adults. That's pretty substantial. Obviously no one knows what Phase 3 will show, but cynicism seems unwarranted at this point. https://investor.lilly.com/news-releases/news-release-details/lillys-phase-2-results-published-new-england-journal-medicine https://investor.lilly.com/news-releases/news-release-detail...
- timewizard 2y ago[flagged]
- derektank 2y agoI don't understand what your criticism is here exactly. Of course Eli Lilly will release a press release if the results of a clinical trial are good but that doesn't make the underlying research (published in the Lancet [1]) suspect in any way. Clinical trials are overseen by the FDA and frequently conducted by third party research scientists without a financial stake in the long term success of the intervention being studied. In this case, it appears that the study authors were researchers at Velocity Clinical Research and they found significant body weight loss with side effects comparable with other GLP-1 agonists. Skepticism might be warranted, particularly until phase 3 trials are conducted, but mindless cynicism hardly seems warranted. [1] https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01302-8/abstract https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
- _ihaque 2y agoThose wondering about the mouthful of a name that is "orforglipron" may be interested in the INN (international nonproprietary name) standard for generic drugs. That name is a "generic" or "nonproprietary" name. Those typically have a "stem" which indicate the mechanism by which the drug works. In this case, it's "-glipron", which you can parse as "glipr" -- GLP-1 receptor -- and "on" -- it's an "agonist", or something that turns "on" the receptor. So "-glipron"s are drugs which agonize, or activate, the GLP-1 receptor. There are other gliprons in trials, including danuglipron (https://en.wikipedia.org/wiki/Danuglipron https://en.wikipedia.org/wiki/Danuglipron) from Pfizer, and many others that don't have assigned INNs. Semaglutide and liraglutide also agonize GLP-1, so why aren't they gliprons? Because chemically they are analogs of the naturally occurring GLP-1 peptide, so they get the -glutide (GLUcagon-like pepTIDE) stem. I don't know why tirzepatide got that name. It's a peptide, so "-tide" makes sense, but it's actually listed as a "various" exception in the master document of INNs: https://iris.who.int/bitstream/handle/10665/379226/9789240099388-eng.pdf?sequence=1 https://iris.who.int/bitstream/handle/10665/379226/978924009....
- hnburnsy 2y agoThe pipeline for weight loss drugs is quite full and can be found here... >Industry data provider IQVIA pulled together a list of the current obesity pipeline, which features 124 medicines altogether: 61 in phase 1, 47 in phase 2, eight in phase 3 and eight on the market. https://www.fiercebiotech.com/biotech/late-breaking-obesity-glp-1-wegovy-zepbound-novo-lilly-pipeline-rd-landscape https://www.fiercebiotech.com/biotech/late-breaking-obesity-...
- seydor 2y agoIn a world were everyone is lean and ripped, i wonder if it being overweight will become the new sexy again
- londons_explore 2y agoNo, it'll mean 'Im too lazy to go to my GP and get weight loss medication'. Same as people who can't be bothered to comb their hair.
- tqi 2y ago> Same as people who can't be bothered to comb their hair. which was definitely considered a desirable look at various times.
- derektank 2y agoNo medication to make people ripped (yet). Though I have to imagine someone is trying to find a way to induce myostatin-related muscle hypertrophy without gene therapy.
- toomuchtodo 2y agoThere is a pathway to target that encourages muscle growth without exercise, but it increases cancer risk.
- loeg 2y agoUh, also heart attack / stroke. (We're talking about anabolic steroids, right?)
- toomuchtodo 2y agoMyostatin inhibitor mechanisms [1] [2] [3]. I see this pathway, GLP-1 successors, and rewriting adipose tissue memory [4] [5] as the holy grail of weight loss, muscle gain, and weight/composition management with little effort. Diet and exercise? Old and busted. Hormone orchestration is the new hotness (with perhaps a touch of gene therapy if needed). "We fixed the glitch." [1] https://en.wikipedia.org/wiki/Myostatin https://en.wikipedia.org/wiki/Myostatin [2] https://www.jci.org/articles/view/148372 https://www.jci.org/articles/view/148372 [3] https://today.uconn.edu/2025/02/next-generation-of-weight-loss-drugs-being-researched-at-uconn/ https://today.uconn.edu/2025/02/next-generation-of-weight-lo... [4] https://portlandpress.com/bioscirep/article/33/5/e00065/56102/Turning-WAT-into-BAT-a-review-on-regulators https://portlandpress.com/bioscirep/article/33/5/e00065/5610... [5] https://www.nature.com/articles/s41586-024-08165-7 https://www.nature.com/articles/s41586-024-08165-7 (not a medical professional, but i do not recommend anabolic steroid use except under the recommendation and supervision of a medical professional)
- deleted 2y ago[deleted]
- haltingproblem 2y agoP/E of 73. What can go wrong?
- Frederation 2y agoGet the nation a steady diet of HFCS's and related "sugar substitutes". Check. Foster drug science to create ways to get people thin, again. Check. Gets you coming and going. Noice.